Literature DB >> 20540665

Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions.

Sudhindra Mohan Bhattacharya1.   

Abstract

AIM: To compare the prevalence rate of metabolic syndrome (MS) in women with polycystic ovary syndrome (PCOS) using the Adult Treatment Panel III (ATP III) criteria, with that using the International Diabetes Federation (IDF) criteria and also to assess the metabolic risk factors for this syndrome.
METHODS: This was a cross-sectional study, 198 women with PCOS were studied. MS was diagnosed as per the ATP III and IDF criteria, separately.
RESULTS: MS was found in 37.9% cases (ATP III criteria) and 47.5% cases of PCOS (IDF criteria) (p = 0.02). In adolescents, prevalence of MS was more with the IDF criteria (p = 0.009) but in adults, the prevalence rates were similar between the two criteria (p = 0.08). Women with MS had significantly higher body mass index, irrespective of age and the definition used. Dyslipidemia was found more common than elevated fasting glucose abnormality, using either of the criteria.
CONCLUSION: Prevalence rate of MS in PCOS depends on the definition used. With IDF criteria, in the whole group, the prevalence was significantly higher. A universally accepted definition of MS, suitable for adolescents and adults, is urgently needed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540665     DOI: 10.3109/09513590903367010

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  9 in total

1.  Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome.

Authors:  Cindy Ta Pau; Candace C Keefe; Corrine K Welt
Journal:  Gynecol Endocrinol       Date:  2013-06       Impact factor: 2.260

2.  Waist-to-height ratio and BMI as predictive markers for insulin resistance in women with PCOS in Kolkata, India.

Authors:  Koushik Bhattacharya; Pallav Sengupta; Sulagna Dutta; Prasenjit Chaudhuri; Lipika Das Mukhopadhyay; Alak Kumar Syamal
Journal:  Endocrine       Date:  2021-01-05       Impact factor: 3.633

3.  Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years.

Authors:  Charles J Glueck; John A Morrison; Stephen Daniels; Ping Wang; Davis Stroop
Journal:  J Pediatr       Date:  2011-03-01       Impact factor: 4.406

4.  Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy.

Authors:  Kui Yao; Ce Bian; Xia Zhao
Journal:  Exp Ther Med       Date:  2017-06-22       Impact factor: 2.447

Review 5.  Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Jamal Hallajzadeh; Maliheh Khoramdad; Nahid Karamzad; Amir Almasi-Hashiani; Ali Janati; Erfan Ayubi; Reza Pakzad; Mark J M Sullman; Saeid Safiri
Journal:  J Cardiovasc Thorac Res       Date:  2018-05-28

6.  Body Composition, Metabolic Characteristics, and Insulin Resistance in Obese and Nonobese Women with Polycystic Ovary Syndrome.

Authors:  Anil Satyaraddi; Kripa Elizabeth Cherian; Nitin Kapoor; Aleyamma Thaiparambil Kunjummen; Mohan S Kamath; Nihal Thomas; Thomas V Paul
Journal:  J Hum Reprod Sci       Date:  2019 Apr-Jun

7.  Prevalence of hepatic steatosis in women with polycystic ovary syndrome.

Authors:  Ritu Karoli; Jalees Fatima; Ashok Chandra; Uma Gupta; Faraz-Ul Islam; Gagandeep Singh
Journal:  J Hum Reprod Sci       Date:  2013-01

8.  Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.

Authors:  Iram Shabir; Mohd Ashraf Ganie; Mohd Afzal Zargar; Dilafroz Bhat; Mohd Muzzafar Mir; Aleem Jan; Zaffar Amin Shah; Vicar Jan; Riyaz Rasool; Andleeb Naqati
Journal:  Indian J Endocrinol Metab       Date:  2014-05

9.  Adiponectin Gene Polymorphism (rs17300539) Has No Influence on the Occurrence of Metabolic Syndrome in Women with Polycystic Ovary Syndrome.

Authors:  Izabela Nowak; Sylwester Ciećwież; Beata Łój; Jacek Brodowski; Agnieszka Brodowska
Journal:  Genes (Basel)       Date:  2021-11-27       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.